Literature DB >> 11070040

Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 tax transactivation of the serum response element.

M Shuh1, D Derse.   

Abstract

The human T-cell leukemia virus type 1 Tax protein activates the expression of cellular immediate early genes controlled by the serum response element (SRE), which contains both the serum response factor (SRF) binding element (CArG box) and the ternary complex factor (TCF) binding element (Ets box). We show that TCF binding is necessary for Tax activation of the SRE and that Tax directly interacts with TCFs in vitro. In addition, Tax interactions with CREB binding protein (CBP) and p300- and CBP-associated factor were found to be essential for Tax activation of SRF-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070040      PMCID: PMC113245          DOI: 10.1128/jvi.74.23.11394-11397.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1.

Authors:  Z L Chu; Y A Shin; J M Yang; J A DiDonato; D W Ballard
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

2.  Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF.

Authors:  R A Hipskind; V N Rao; C G Mueller; E S Reddy; A Nordheim
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

3.  MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP.

Authors:  R Janknecht; A Nordheim
Journal:  Biochem Biophys Res Commun       Date:  1996-11-21       Impact factor: 3.575

4.  Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells.

Authors:  T M Ross; M Narayan; Z Y Fang; A C Minella; P L Green
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein.

Authors:  E W Harhaj; S C Sun
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

6.  The CREB-binding protein (CBP) cooperates with the serum response factor for transactivation of the c-fos serum response element.

Authors:  S Ramirez; S Ait-Si-Ali; P Robin; D Trouche; A Harel-Bellan; S Ait Si Ali
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner.

Authors:  H Jiang; H Lu; R L Schiltz; C A Pise-Masison; V V Ogryzko; Y Nakatani; J N Brady
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

8.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.

Authors:  M R Smith; W C Greene
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

9.  Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.

Authors:  R Geleziunas; S Ferrell; X Lin; Y Mu; E T Cunningham; M Grant; M A Connelly; J E Hambor; K B Marcu; W C Greene
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element.

Authors:  C Norman; M Runswick; R Pollock; R Treisman
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

View more
  14 in total

1.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.

Authors:  Ling Gao; Hongju Deng; Haibo Zhao; Angela Hirbe; John Harding; Lee Ratner; Katherine Weilbaecher
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex.

Authors:  M Hassler; T J Richmond
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Human T-cell leukemia virus type 1 Tax enhances serum response factor DNA binding and alters site selection.

Authors:  Heather Y Winter; Susan J Marriott
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo.

Authors:  C Merezak; M Reichert; C Van Lint; P Kerkhofs; D Portetelle; L Willems; R Kettmann
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 5.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

6.  Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.

Authors:  Dmitriy Mazurov; Anna Ilinskaya; Gisela Heidecker; Patricia Lloyd; David Derse
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

7.  Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.

Authors:  Nicholas Polakowski; Heather Gregory; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  Retrovirology       Date:  2010-07-23       Impact factor: 4.602

8.  Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1.

Authors:  Heather Y Winter; Tajhal Dayaram; Susan J Marriott
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

9.  SR-related protein TAXREB803/SRL300 is an important cellular factor for the transactivational function of human T-cell lymphotropic virus type 1 Tax.

Authors:  Hwang-Geum Youn; Jun Matsumoto; Yuetsu Tanaka; Kunitada Shimotohno
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.